# China NMPA Drug Inspection - Tianma (Anhui) Traditional Chinese Medicine Pieces Technology Co., Ltd. - Stir-fried Atractylodes lancea

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/tianma-anhui-traditional-chinese-medicine-pieces-technology-co-ltd/e9e99bb3-d489-4c61-9244-b9eff509fd35/
Source feed: China

> China NMPA drug inspection for Tianma (Anhui) Traditional Chinese Medicine Pieces Technology Co., Ltd. published June 29, 2018. Drug: Stir-fried Atractylodes lancea. The Henan Provincial Food and Drug Administration announced on June 29, 2018, that four batches of traditional Chinese m

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from the Henan Provincial Food and Drug Administration regarding four batches of substandard drugs (Issue No. 7, 2018)
- Company Name: Tianma (Anhui) Traditional Chinese Medicine Pieces Technology Co., Ltd.
- Publication Date: 2018-06-29
- Drug Name: Stir-fried Atractylodes lancea
- Inspection Finding: The non-compliant item was content.
- Action Taken: The Henan Provincial Food and Drug Administration has instructed relevant food and drug regulatory departments to take necessary risk control measures such as sealing, seizing, and suspending sales of substandard drugs, and to investigate and punish the units that sourced the samples in accordance with the law.
- Summary: The Henan Provincial Food and Drug Administration announced on June 29, 2018, that four batches of traditional Chinese medicine pieces from three manufacturers were found to be substandard following inspections by Luoyang and Kaifeng Municipal Food and Drug Inspection Institutes. Anhui Yishengyuan Traditional Chinese Medicine Pieces Technology Co., Ltd.'s Atractylodes lancea (batch 160601) was non-compliant due to its moisture content. Tianma (Anhui) Traditional Chinese Medicine Pieces Technology Co., Ltd. had an issue with Atractylodes lancea stir-fried with wheat bran (batch 150401), which was found substandard in both content and moisture levels. Additionally, Bozhou Municipal Traditional Chinese Medicine Slices Factory had two batches of Atractylodes lancea products (batch 170223, both plain and stir-fried with wheat bran) that failed to meet content specifications. These findings are based on standards set forth in the Chinese Pharmacopoeia (2010 and 2015 Editions, Part I). In response, the Henan Provincial Food and Drug Administration has directed local regulatory bodies to implement immediate risk control measures, including sealing, seizing, and suspending sales of the affected drugs. Furthermore, investigations and legal penalties are mandated against the manufacturing entities responsible for these substandard products to ensure compliance and public safety.

Company: https://www.globalkeysolutions.net/companies/tianma-anhui-traditional-chinese-medicine-pieces-technology-co-ltd/20444e35-fe0d-4727-8e2f-c3504efee4ee/